| Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes R Cristescu, J Lee, M Nebozhyn, KM Kim, JC Ting, SS Wong, J Liu, ... Nature medicine 21 (5), 449-456, 2015 | 2295 | 2015 |
| Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer ST Kim, R Cristescu, AJ Bass, KM Kim, JI Odegaard, K Kim, XQ Liu, ... Nature medicine 24 (9), 1449-1458, 2018 | 1655 | 2018 |
| Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 … J Lee, DH Lim, S Kim, SH Park, JO Park, YS Park, HY Lim, MG Choi, ... Journal of clinical oncology 30 (3), 268-273, 2012 | 1038 | 2012 |
| Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer: final report of the adjuvant … SH Park, TS Sohn, J Lee, DH Lim, ME Hong, KM Kim, I Sohn, SH Jung, ... Journal of clinical oncology 33 (28), 3130-3136, 2015 | 523 | 2015 |
| Individual patient data meta-analysis of the value of microsatellite instability as a biomarker in gastric cancer F Pietrantonio, R Miceli, A Raimondi, YW Kim, WK Kang, RE Langley, ... Journal of Clinical Oncology 37 (35), 3392-3400, 2019 | 520 | 2019 |
| Improved survival of gastric cancer with tumour Epstein–Barr virus positivity: an international pooled analysis MC Camargo, WH Kim, AM Chiaravalli, KM Kim, AH Corvalan, K Matsuo, ... Gut 63 (2), 236-243, 2014 | 463 | 2014 |
| Genomic heterogeneity as a barrier to precision medicine in gastroesophageal adenocarcinoma E Pectasides, MD Stachler, S Derks, Y Liu, S Maron, M Islam, L Alpert, ... Cancer discovery 8 (1), 37-48, 2018 | 330 | 2018 |
| A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive … SH Park, DH Lim, TS Sohn, J Lee, DY Zang, ST Kim, JH Kang, SY Oh, ... Annals of Oncology 32 (3), 368-374, 2021 | 310 | 2021 |
| Comparing MR imaging and CT in the staging of gastric carcinoma KM Sohn, JM Lee, SY Lee, BY Ahn, SM Park, KM Kim American journal of roentgenology 174 (6), 1551-1557, 2000 | 301 | 2000 |
| Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta … BCV Campbell, WH Van Zwam, M Goyal, BK Menon, DWJ Dippel, ... The Lancet Neurology 17 (1), 47-53, 2018 | 284 | 2018 |
| Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Korea 2000-2009: multicenter study MY Cho, JM Kim, JH Sohn, MJ Kim, KM Kim, WH Kim, H Kim, MC Kook, ... Cancer research and treatment: official journal of Korean Cancer Association …, 2012 | 275 | 2012 |
| Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial. JH Schiller, K Kim, P Hutson, R DeVore, J Glick, J Stewart, D Johnson Journal of clinical oncology 14 (8), 2345-2352, 1996 | 267 | 1996 |
| Validation of microsatellite instability detection using a comprehensive plasma-based genotyping panel J Willis, MI Lefterova, A Artyomenko, PM Kasi, Y Nakamura, K Mody, ... Clinical Cancer Research 25 (23), 7035-7045, 2019 | 261 | 2019 |
| A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors MJ Alvarez, PS Subramaniam, LH Tang, A Grunn, M Aburi, G Rieckhof, ... Nature genetics 50 (7), 979-989, 2018 | 233 | 2018 |
| Tumor genomic profiling guides patients with metastatic gastric cancer to targeted treatment: the VIKTORY umbrella trial J Lee, ST Kim, K Kim, H Lee, I Kozarewa, PGS Mortimer, JI Odegaard, ... Cancer discovery 9 (10), 1388-1405, 2019 | 228 | 2019 |
| Low-level microsatellite instability in most colorectal carcinomas P Laiho, V Launonen, P Lahermo, M Esteller, M Guo, JG Herman, ... Cancer research 62 (4), 1166-1170, 2002 | 226 | 2002 |
| Host inflammatory response predicts survival of patients with Epstein-Barr virus–associated gastric carcinoma HJ Song, A Srivastava, J Lee, YS Kim, KM Kim, WK Kang, M Kim, S Kim, ... Gastroenterology 139 (1), 84-92. e2, 2010 | 222 | 2010 |
| Determinants of response and intrinsic resistance to PD-1 blockade in microsatellite instability–high gastric cancer M Kwon, M An, SJ Klempner, H Lee, KM Kim, JK Sa, HJ Cho, JY Hong, ... Cancer discovery 11 (9), 2168-2185, 2021 | 218 | 2021 |
| Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy JK Lee, Z Liu, JK Sa, S Shin, J Wang, M Bordyuh, HJ Cho, O Elliott, T Chu, ... Nature genetics 50 (10), 1399-1411, 2018 | 216 | 2018 |
| Prevalence and detection of low-allele-fraction variants in clinical cancer samples HT Shin, YL Choi, JW Yun, NKD Kim, SY Kim, HJ Jeon, JY Nam, C Lee, ... Nature communications 8 (1), 1377, 2017 | 215 | 2017 |
Byung-Hoon MinSungkyunkwan UniversityVerified email at skku.edu
